In vitro activities in new oxazolidinone antimicrobial agents against enterococci | Zendy

George M. Eliopoulos | Zendy; Christine Wennersten | Zendy; Howard S. Gold | Zendy; Robert C. Moellering | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

In vitro activities in new oxazolidinone antimicrobial agents against enterococci

Author(s) -

George M. Eliopoulos,

Christine Wennersten,

Howard S. Gold,

Robert C. Moellering

Publication year - 1996

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.40.7.1745

Subject(s) - antimicrobial , agar dilution , minocycline , ampicillin , agar dilution method , microbiology and biotechnology , in vitro , agar , enterococcus , antibacterial agent , vancomycin , biology , antibiotics , chemistry , bacteria , minimum inhibitory concentration , staphylococcus aureus , biochemistry , genetics

The comparative in vitro activities of two new oxazolidinone antimicrobial agents, U-100592 and U-100766, against 180 isolates of enterococci representing several resistance profiles were examined by using an agar dilution technique. The two oxazolidinones inhibited all isolates, including strains resistant to vancomycin, ampicillin, and minocycline, at concentrations between 1 and 4 micrograms/ml.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research